Related Experiment Video
Updated: May 6, 2026
09:03
Eye Tracking Young Children with Autism
Published on: March 27, 2012
45.5K
Tourette syndrome research highlights from 2023
Andreas Hartmann1, Per Andrén2, Cyril Atkinson-Clement3
1Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hopitaux de Paris, Paris, Île-de-France, 75013, France.
F1000Research
|September 19, 2024
Summary
This annual update reviews 2023 research on Gilles de la Tourette syndrome and other tic disorders. We invite reader contributions to advance understanding of these complex neurological conditions.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Gilles de la Tourette syndrome (GTS) and other tic disorders represent complex neurological conditions.
- Annual updates are crucial for synthesizing the latest research findings.
Purpose of the Study:
- To provide a comprehensive summary of research published in 2023 concerning GTS and related tic disorders.
- To highlight key advancements and emerging trends in the field.
Main Methods:
- Systematic review of research articles published in the F1000Research Tics collection during 2023.
- Categorization and synthesis of findings related to etiology, diagnosis, and treatment of tic disorders.
Main Results:
- The 2023 collection encompasses a range of studies on tic disorders.
- Key themes likely include genetic factors, neurobiological underpinnings, and therapeutic interventions.
Conclusions:
- The F1000Research Tics collection serves as a valuable resource for the scientific community.
- Continued research and open dialogue are essential for improving the lives of individuals with tic disorders.
Keywords:
Tics; Tourette; annual review
Related Concept Videos
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28